ASX:4DXHealthcare Services
A Look At 4DMedical’s (ASX:4DX) Valuation After Its New GlaxoSmithKline Lung Imaging Contract
4DMedical (ASX:4DX) has secured a one-year contract with GlaxoSmithKline, in association with Flywheel Exchange, to supply quantitative lung imaging analytics for pulmonary drug development and clinical research starting May 1, 2026.
See our latest analysis for 4DMedical.
The GlaxoSmithKline agreement, recent inclusion in the S&P/ASX 200 Index and the upcoming AI & Technology Virtual Investor Conference sit alongside a share price of A$5.27, with a 30 day share price return of 13.82% and a 90...